首页 > 市场调查报告书 > 医疗设备

生技设备

全EXOME市场规模、份额和成长分析（按产品、技术、工作流程、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897358

全EXOME市场规模、份额和成长分析（按产品、技术、工作流程、应用、最终用户和地区划分）－2026-2033年产业预测

Whole Exome Sequencing Market Size, Share, and Growth Analysis, By Product, By Technology, By Workflow, By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球全EXOME定序市场规模预计在 2024 年达到 5.8334 亿美元，从 2025 年的 6.8484 亿美元增长到 2033 年的 24.7135 亿美元，在预测期（2026-2033 年）内复合年增长率为 17.4%。

全球全EXOME定序市场正经历显着成长，这主要得益于技术进步、在研究和诊断领域应用范围的扩大以及成本的下降。对精准快速检测遗传性疾病和慢性病的需求日益增长，推动了该行业的扩张，医疗专业人员越来越多地利用全EXOME子组测序来发现与各种疾病相关的基因突变。这项技术能够根据个体的基因组特征制定个人化治疗方案。随着这些技术的普及和成本效益的提高，医疗机构对其的采用率也不断上升。以特定基因标记为基础的个人化医疗趋势，代表着该行业一条充满前景的发展道路，而持续的技术创新有望进一步提升医疗保健领域的诊断能力和治疗策略。

推动全球全外EXOME定序发展的因素

推动全球全EXOME序市场扩张的关键因素之一是人们对个人化医疗日益增长的需求。透过分析个体的全EXOME，医疗服务提供者可以根据每位患者独特的基因谱和疾病易感性制定个人化的治疗方案。这种客製化方法能够提高治疗效果，最终改善患者的预后。此外，定序技术和数据分析的不断进步使得全EXOME定序越来越普及且成本更低，从而促进了其在临床上的应用。随着个人化医疗的重要性日益凸显，对全EXOME定序的需求将持续增长，并对医疗保健格局产生深远影响。

限制全球全EXOME定序市场

全EXOME定序市场面临巨大的挑战，这主要是由于其产生的大量基因组数据具有复杂度和解读难度。分析和解读这些庞大的遗传讯息通常耗时费力，并且需要专业知识。此外，确保结果的准确性和可靠性对于做出明智的医疗决策至关重要。这需要先进的生物资讯学工具和专业知识来有效管理和解读数据，而这些因素可能会阻碍全外EXOME子定序的广泛应用。这些限制最终可能会限制其在各种医疗保健环境中的可用性和实际应用。

全球全外EXOME定序市场趋势

人工智慧 (AI) 和机器学习 (ML) 技术在资料分析和解读过程中的融合是全球全EXOME定序市场的一大趋势。这些先进的分析工具正被越来越多地用于管理全外EXOME定序产生的大量基因组数据，从而能够识别重要的遗传模式、突变和疾病关联。透过自动化数据处理和提高准确性，AI 和 ML 正在改变基因组分析的格局，实现更快、更准确地检测基因突变。这种整合不仅有助于提高诊断准确性和个人化治疗方案，还促进了基因组医学的发展，从而显着推动了全EXOME序市场的成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Illumina, Inc.（USA）
Thermo Fisher Scientific, Inc.（USA）
Agilent Technologies, Inc.（USA）
Pacific Biosciences of California, Inc.（PacBio）（USA）
Oxford Nanopore Technologies plc.（UK）
BGI Genomics Co., Ltd.（China）
Eurofins Scientific SE（Luxembourg）
Bio-Rad Laboratories, Inc.（USA）
Novogene Co., Ltd.（China）
Azenta, Inc.（formerly GENEWIZ）（USA）
CD Genomics（USA）
Psomagen, Inc.（South Korea）
F. Hoffmann-La Roche AG（Switzerland）
10x Genomics, Inc.（USA）
Bionano Genomics, Inc.（USA）
Dante Labs（Italy）
MGI Tech Co., Ltd.（China）
GeneDx Holdings Corp.（USA）
Helix OpCo, LLC（USA）

结论与建议

简介目录

Product Code: SQMIG35H2119

Global Whole Exome Sequencing Market size was valued at USD 583.34 Million in 2024 and is poised to grow from USD 684.84 Million in 2025 to USD 2471.35 Million by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The global market for whole exome sequencing is experiencing notable growth driven by advancements in technology, expanding applications in research and diagnostics, and decreasing costs. The rising demand for accurate and timely detection of genetic and chronic diseases has accelerated industry expansion, with healthcare professionals increasingly leveraging whole exome sequencing to uncover genetic variations linked to various conditions. This capability facilitates the development of personalized treatments tailored to individual genomic profiles. As such technologies become more accessible and cost-effective, healthcare facilities are adopting them at higher rates. The trend towards personalized medicine, where treatment is based on specific genetic markers, indicates a promising trajectory for the industry, with ongoing innovations likely to further enhance diagnostic capabilities and therapeutic strategies in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segments Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A significant factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans to align with each patient's unique genetic profile and vulnerability to diseases. This customized approach enhances the effectiveness of therapies, ultimately leading to better patient outcomes. Additionally, continuous advancements in sequencing technologies and data analysis are making whole exome sequencing increasingly accessible and cost-effective, thereby promoting its utilization in clinical environments. As the importance of individualized healthcare becomes more recognized, the demand for whole exome sequencing continues to grow, influencing the healthcare landscape.

Restraints in the Global Whole Exome Sequencing Market

The whole exome sequencing market encounters notable challenges due to the complexity and interpretation difficulties linked to the substantial volumes of genomic data produced. The analysis and interpretation of this extensive genetic information are often time-intensive and demand specialized knowledge. Furthermore, guaranteeing the accuracy and reliability of results is vital for informed medical decision-making. This necessitates the availability of advanced bioinformatics tools and expertise to effectively manage and interpret the data, which can hinder the widespread adoption of whole exome sequencing. Such constraints can ultimately limit its accessibility and practical application within various healthcare environments.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is experiencing a notable trend with the incorporation of artificial intelligence (AI) and machine learning (ML) technologies into data analysis and interpretation processes. These advanced analytical tools are increasingly utilized to manage the vast amounts of genomic data generated from whole exome sequencing, enabling the identification of crucial genetic patterns, variations, and disease correlations. By automating data processing and enhancing accuracy, AI and ML are changing the landscape of genomic analysis, leading to more rapid and precise detection of genetic variants. This integration not only supports improved diagnoses and personalized treatment options but also propels advancements in genomic medicine, positioning the whole exome sequencing market for significant growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Consumables
System
Kits
Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2026-2033)

Market Overview
Sequencing by Synthesis
ION Semiconductor Sequencing
Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2026-2033)

Market Overview
Pre-Sequencing
Sequencing
Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Agriculture and Animal Research
Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2026-2033)

Market Overview
Academic And Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Global Whole Exome Sequencing Market Size & CAGR (2026-2033)

North America (Product, Technology, Workflow, Application, End-use)
- US
- Canada
Europe (Product, Technology, Workflow, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Workflow, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Workflow, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Workflow, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (PacBio) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novogene Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta, Inc. (formerly GENEWIZ) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CD Genomics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psomagen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionano Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dante Labs (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MGI Tech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneDx Holdings Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helix OpCo, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments